tiprankstipranks
Advertisement
Advertisement

AU:PTX Stock Latest News

Prescient Tightens Governance With Updated Securities Trading Policy
Company AnnouncementsPrescient Tightens Governance With Updated Securities Trading Policy
1M ago
PTX
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
PremiumCompany Announcements
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
1M ago
PTX
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
PremiumCompany Announcements
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
2M ago
PTX
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
PremiumCompany Announcements
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
3M ago
PTX
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
PremiumCompany Announcements
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
3M ago
PTX
Prescient Therapeutics Announces Director’s Interest Change
PremiumCompany AnnouncementsPrescient Therapeutics Announces Director’s Interest Change
4M ago
PTX
Prescient Therapeutics Announces Director’s Change in Securities Interest
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Change in Securities Interest
4M ago
PTX
Director’s Interest Update at Prescient Therapeutics
Premium
Company Announcements
Director’s Interest Update at Prescient Therapeutics
4M ago
PTX
Prescient Therapeutics Announces Director’s Acquisition of Options
PremiumCompany Announcements
Prescient Therapeutics Announces Director’s Acquisition of Options
4M ago
PTX
Prescient Therapeutics Director Acquires New Options
PremiumCompany Announcements
Prescient Therapeutics Director Acquires New Options
4M ago
PTX
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
PremiumCompany Announcements
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
4M ago
PTX
Prescient Therapeutics Issues New Employee Incentive Options
PremiumCompany Announcements
Prescient Therapeutics Issues New Employee Incentive Options
4M ago
PTX
Prescient Therapeutics Amends Constitution to Support Strategic Goals
PremiumCompany AnnouncementsPrescient Therapeutics Amends Constitution to Support Strategic Goals
5M ago
PTX
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
Premium
Company Announcements
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
5M ago
PTX
Prescient Therapeutics Advances PTX-100 with Strategic Milestones
Premium
Company Announcements
Prescient Therapeutics Advances PTX-100 with Strategic Milestones
6M ago
PTX
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
PremiumCompany Announcements
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
6M ago
PTX
Prescient Therapeutics Announces Hybrid Annual General Meeting
PremiumCompany Announcements
Prescient Therapeutics Announces Hybrid Annual General Meeting
7M ago
PTX
Prescient Therapeutics Issues New Unquoted Equity Securities
PremiumCompany Announcements
Prescient Therapeutics Issues New Unquoted Equity Securities
7M ago
PTX
Prescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
PremiumCompany Announcements
Prescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
7M ago
PTX
Prescient Therapeutics Lists New Securities on ASX
PremiumCompany AnnouncementsPrescient Therapeutics Lists New Securities on ASX
7M ago
PTX
Prescient Therapeutics Releases Corporate Governance Statement
Premium
Company Announcements
Prescient Therapeutics Releases Corporate Governance Statement
7M ago
PTX
Prescient Therapeutics Reports Financial Results with Focus on R&D Investment
Premium
Company Announcements
Prescient Therapeutics Reports Financial Results with Focus on R&D Investment
7M ago
PTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >